Author Archives: webmaster

Participation of members from Oslo Diabetes Research Centre at EASD 2017

Several abstracts by  members from  Oslo Diabetes Research Centre have been accepted for presentation at the annual EASD in Lisboa September 11-15, 2017: 1. Time-trends in incidence and prevalence of type 2 diabetes patients requiring glucose-lowering treatment from 2007-2015: nationwide data from Norway and Sweden. D. Nathanson, J. Bodegard, A. Norhammar, K.I. Birkeland, T. Nyström, M. Thuresson, […]

Lower risk of heart failure, cardiovascular disease and overall mortality in patients with type 2 diabetes following initiation of SGLT2 inhibitors

The article Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis, recently published in Lancet Diabetes & Endocrinology,  shows that the use of sodium-glucose co-transporter-2 (SGLT2) inhibitors in normal clinical practice is associated with lower risk of heart failure, cardiovascular […]

Disputation: Vibeke Gagnum

Vibeke Gagnum defends her doctoral dissertation for the degree of Ph.d.: Mortality, causes of death and end-stage renal disease in type 1 diabetes. Time and place: June 13th 2017 at 13:15, Gamle Festsal, Domus Academica (Urbygningen). Her trial lecture will be held on June 13th 2017 at 10:15, Gamle Festsal, Domus Academica (Urbygningen). Read more